


Dr. Stuart Orkin, MD
Dr. Stuart Orkin, MD is a pediatric hematologist oncologist in Boston, MA. He is affiliated with medical facilities Boston Children's Hospital and Dana-Farber Cancer Institute. He is accepting new patients.
Practice
44 Binney St Boston, MA 02115Biography
Dr. Orkin received his me..."
- Dr. Stuart Orkin, MD
At a Glance
- Area of Expertise

Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Orkin's Reviews
Overall Patient Satisfaction
About Me
biography
Dr. Stuart Orkin is Chairman of Pediatric Oncology and Associate Chief of the Division of Hematology/Oncology at Boston Children's Hospital, specializing in Pediatric Cancer Care.Dr. Orkin received his medical education from Harvard Medical School and completed his training at Boston Children's Hospital.
Pediatric Hematology & Oncology
Pediatrics
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Boston Children's Hospital
Fellowship Hospital
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkSox2 maintains self-renewal of tumor initiating cells in osteosarcomas, 2011-09-19
Chronic myelogenous leukemia initiating cells require Polycomb group protein EZH2, 2016-09-14
Chromatin connections to pluripotency and cellular reprogramming, 2011-06-10
Transcription control by the ENL YEATS domain in acute leukemia, 2017-03-01
High fat diet enhances stemness and tumorigenicity of intestinal progenitors, 2016-03-03
Reactivation of a developmentally silenced embryonic globin gene, 2021-07-21
Advances in the understanding of haemoglobin switching, 2010-03-01
MicroRNA 21 promotes fibrosis of the kidney by silencing metabolic pathways, 2012-02-15
A SinglecisElement Maintains Repression of the Key Developmental RegulatorGata2, 2010-09-09
MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets, 2012-03-16
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis, 2019-06-28
Prmt1-mediated translation regulation is a crucial vulnerability of cancer, 2017-06-27
A Comparative Encyclopedia of DNA Elements in the Mouse Genome, 2014-11-20
CUT&RUNTools: a flexible pipeline for CUT&RUN processing and footprint analysis, 2019-09-09
Mapping cellular hierarchy by single cell analysis of the cell surface repertoire, 2013-09-12
Mouse regulatory DNA landscapes reveal global principles ofcis-regulatory evolution, 2014-11-21
Polycomb Repressive Complex 2 Regulates Normal Development of the Mouse Heart, 2011-12-08
Functional interrogation of non-coding DNA through CRISPR genome editing, 2017-03-10
Update on fetal hemoglobin gene regulation in hemoglobinopathies, 2011-04-19
SWI/SNF mutant cancers depend upon catalytic and non-catalytic activity of EZH2, 2015-11-09
Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium, 2012-08-03
Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts, 2022-07-06
A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin, 2022-12-14
Developmental and species-divergent globin switching are driven by BCL11A, 2009-08-05
Transcription factor competition at the ?-globin promoters controls hemoglobin switching, 2021-05-28
Transcription factor competition at the ?-globin promoters controls hemoglobin switching, 2021-03-01
Acquired tissue-specific promoter bivalency is a basis for PRC2 necessity in adult cells, 2016-05-19
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch, 2018-03-29
Regulation of haematopoietic multipotency by EZH1, 2018-01-17
ReducedErgdosage impairs survival of hematopoietic stem and progenitor cells, 2017-04-24
Bcl11a-deficiency leads to hematopoietic stem cell defects with an aging-like phenotype, 2016-09-20
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer, 2013-08-25
A unified model of human hemoglobin switching through single-cell genome editing, 2021-08-17
TIF1? controls erythroid cell fate by regulating transcription elongation, 2010-07-09
A human stem cell model of early Alzheimer's disease pathology in Down syndrome, 2012-02-15
LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice, 2015-12-02
The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability, 2015-04-14
Analyzing CRISPR genome editing experiments with CRISPResso, 2016-07-12
Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9, 2014-01-03
Identifying quantitatively differential chromosomal compartmentalization changes and their biological significance from Hi-C data using DARIC, 2023-10-13
Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis, 2016-07-01
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells, 2019-08-07
Mapping the evolving landscape of super-enhancers during cell differentiation, 2021-09-15
Focus on Breast Cancer
Locations
Practice
Affiliated Hospitals
Compare Providers
Providers shown based on Dr. Orkin's location and specialty. Show more Pediatric Oncologists & Pediatric Hematologists.